| 07/01/2026 17:45 |
Corporate Governance Report |
| 06/25/2026 16:00 |
Notice Concerning Disposal of Treasury Shares as Restricted Share Compensation |
| 06/04/2026 15:00 |
Membership-based Comprehensive Medical Club "the GRAND HIMEDIC Club" Launches "HIMEDIC Yokohama Bay Course" Service |
| 06/04/2026 15:00 |
The GRAND HIMEDIC Club "HIMEDIC Yokohama Bay Course"Introduces "ONSEI Pro," an AI-Powered Cognitive Function Self-Check Application |
| 06/02/2026 08:00 |
Notice of Convocation Annual General Meeting 2026 |
| 05/15/2026 16:40 |
Resorttrust Group to Launch "Prestige Nursing," a New Business for Private-Pay Nursing and Lifestyle Support |
| 05/15/2026 16:40 |
CONSOLIDATED FINANCIAL SUMMARY FY2025 (from April 1, 2025 to March 31, 2026) |
| 05/15/2026 16:40 |
Notice Regarding Partial Amendments to the Articles of Incorporation |
| 05/15/2026 16:40 |
Financial results Presentation For the year Ended March 31, 2026 |
| 04/30/2026 16:40 |
CICS, Inc. (a consolidated subsidiary of Resorttrust, Inc.) has submitted a marketing authorization application for the accelerator-based BNCT system |
| 03/13/2026 16:00 |
Notice Regarding Changes in Representative Directors (Modification of Delegated Duties) |
| 02/19/2026 16:45 |
Resorttrust Signs Strategic MOU with Vietnam Hoa Lam Group for Japan-Vietnam Healthcare Business |
| 02/13/2026 12:00 |
CONSOLIDATED FINANCIAL SUMMARY 3Q FY 2025 (from April 1, 2025 to December 31, 2025) |
| 02/13/2026 12:00 |
Financial results Presentation For 9-month Period Ended December 31, 2025 |
| 11/13/2025 12:00 |
CONSOLIDATED FINANCIAL SUMMARY 2Q FY 2025 (from April, 2025 to September, 2025) |
| 11/13/2025 12:00 |
Notice Concerning Disposal of Treasury Shares Through Third-party Allotment Associated with Additional Contribution to the BBT and the J-ESOP |
| 11/13/2025 12:00 |
Financial results Presentation For 6-month Period Ended September 30, 2025 |
| 11/13/2025 12:00 |
Notice of Revision of the Financial Results Forecast,Payment of a Dividend of Surplus (Interim Dividend), and Revision of the Dividend Forecast |
| 10/21/2025 10:00 |
Announcement Concerning the Presentation of Results from the Domestic Phase 2 Clinical Trial at ESMO Congress 2025 |
| 10/01/2025 10:15 |
Announcement of Completion of the Specified Clinical Research of BNCT for Recurrent Breast Cancer, with the Cooperation of CICS |
| 08/13/2025 12:00 |
CONSOLIDATED FINANCIAL SUMMARY 1Q FY 2025 (from April 1, 2025 to June 30, 2025) |
| 08/13/2025 12:00 |
Financial results Presentation For 3-month Period Ended June 30, 2025 |
| 07/28/2025 12:00 |
CICS, Inc. has achieved the primary endpoint in a domestic phase2 clinical trial of BNCT for the treatment of angiosarcoma |
| 07/25/2025 16:30 |
Notice Concerning Completion of Allotment of Treasury Shares Disposed as Restricted Share Compensation |
| 07/07/2025 18:20 |
Corporate Governance Report |
| 07/07/2025 17:20 |
Corporate Governance Report |
